Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in ATOS — Atossa Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to ATOS Full portfolio

Position in ATOS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$30,057
+$30,057 QoQ
Shares Held
15,574
Ownership
0.156%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 31 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATOS Over Time

Shares Held

Position Value (USD)

Derivatives in ATOS

reported options exposure · as of Jun 30, 2026
CallValue
$21,809
CallShares
11,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. ATOS ranks #308 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in ATOS

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,057 15,574
2026-06-30 $21,809 11,300
2026-03-31 $289,300 55,000
2025-12-31 $22,715 38,500
2025-12-31 $343,725 582,587
2025-09-30 $191,053 219,602
2025-09-30 $32,277 37,100
2025-09-30 $23,490 27,000
2025-06-30 $227,349 273,915
2025-06-30 $29,714 35,800
2025-03-31 $26,197 39,100
2025-03-31 $295,024 440,335
2024-12-31 $68,338 72,700
2024-12-31 $212,604 226,176
2024-09-30 $109,093 71,772
2024-09-30 $108,072 71,100
2024-09-30 $548,264 360,700
2024-06-30 $381,276 320,400
2024-06-30 $63,070 53,000
2024-03-31 $73,440 40,800
2024-03-31 $47,700 26,500
2024-03-31 $489,807 272,115
2023-12-31 $180,351 204,945
2023-12-31 $59,664 67,800
2023-09-30 $13,764 18,600
2023-09-30 $183,892 248,504
2023-09-30 $23,606 31,900
2023-06-30 $90,090 71,500
2023-06-30 $470,020 373,032
2023-03-31 $76,062 105,642
2023-03-31 $13,896 19,300
2023-03-31 $30,960 43,000
2022-12-31 $51,139 96,490
2022-12-31 $99,693 188,100
2022-12-31 $13,727 25,900
2022-09-30 $131,306 158,200
2022-09-30 $245,431 295,700
2022-06-30 $85,076 78,052
2022-06-30 $333,976 306,400
2022-06-30 $211,678 194,200
2022-03-31 $346,000 276,800
2022-03-31 $339,500 271,600
2022-03-31 $131,307 105,046
2021-12-31 $885,280 553,300
2021-12-31 $115,430 72,144
2021-12-31 $692,000 432,500
2021-09-30 $805,272 247,016
2021-09-30 $4,960,090 1,521,500
2021-09-30 $2,797,080 858,000
2021-06-30 $20,334,600 3,217,500